fda compounding semaglutide enforcement november 2025 news Diabetes advocacy group discourages use of compounded GLP-1 drugs fda compounding semaglutide enforcement november

58,59 Overall, the future research direction of GLP-1RAs involves making them more similar to those in the human body, extending their duration of action, and creating oral formulations for easier administration

While hemorrhoids from straining are common and usually not serious, blood can indicate other conditions requiring attention

Early research suggests that Retatrutide has a safety profile similar to existing GLP-1 medicines

The goal isnt just short-term loss but sustainable health improvement

All patients were overweight or obese, prediabetic, and taking olanzapine or clozapine

GLP-1s are available either as shots you take at home, or as a pill that is taken by mouth